Citations

Clear

312 citation(s) found for "Siddiqui, U".

First-pass aspiration versus stent retriever thrombectomy: machine learning study of treatment effect heterogeneity
Chen, Huanwen , Isidor, Julio , Schirmer, Clemens, Ernst, Marielle , Rai, Ansaar, Jabbour, Pascal , Abecassis, Isaac Josh , Grossberg, Jonathan A , Alawieh, Ali, Khanna, Omaditya, Starke, Robert M, Psychogios, Marios-Nikos, Siddiqui, Fazeel, Samaniego, E, Goyal, Nitin, Ezzeldin, Mohamad , Dye, Justin, Alcedo, Rodolfo, Cerejo, Russell , Luther, Evan, Romano, Daniele G, Tanweer, Omar, Mascitelli, Justin, Cuellar, Hugo H, Chalouhi, Nohra , Limaye, Kaustubh, Kellogg, Ryan, Brinjikji, Waleed, Chowdhry, Shakeel , Spiotta, Alejandro M , Kan, Peter , Jabbour, Pascal , Abecassis, Isaac Josh , Grossberg, Jonathan A , Navia, Pedro , Ezzeldin, Mohamad , Alaraj, Ali , Yoshimura, Shinichi , Fiorella, David , Fragata, Isabel , Mokin, Maxim , Matouk, Charles , Chowdhry, Shakeel A , Altschul, David J , Ogilvy, Christopher S , Levitt, Michael R , Grandhi, Ramesh , Spiotta, Alejandro M , Kan, Peter , Kim, Jae‐Joong , Rai, Ansaar , Jabbour, Pascal , Navía, Pedro , Starke, Robert M. , Psychogios, Marios‐Nikos , Goyal, Nitin , Dye, Justin , Alaraj, Ali , Yoshimura, Shinichi , Almallouhi, Eyad , Fiorella, David , Romano, Daniele Giuseppe , Tanweer, Omar , Fragata, Isabel , Mascitelli, Justin R , Limaye, Kaustubh , Matouk, Charles , Kellogg, Ryan Thomson , Brinjikji, Waleed , Altschul, David , Ogilvy, Christopher S. , Levitt, Michael R. , Grandhi, Ramesh , Chen, Huanwen

Mayo Clinic

Journal of NeuroInterventional Surgery | July 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: jnis-2026-025615

10.1136/jnis-2026-025615 | PMID 42498630 Get It

Background Randomized trials have shown equivocal outcomes between a direct aspiration as first-pass technique (ADAPT) and stent retriever (SR) stroke thrombectomy, yet whether specific patient subgroups benefit differentially from one technique over the other remains unknown. Methods In this retrospective multicenter cohort study, patients with large vessel occlusion were included, and those who underwent ADAPT versus SR first-pass thrombectomy (either as standalone or combined with aspiration) were compared. The primary outcome was a composite of first-pass effect (FPE, modified Thrombolysis In Cerebral Infarction (mTICI) 2c or better with one attempt) with no symptomatic intracranial hemorrhage (sICH). A causal forest model was used to estimate the conditional average treatment effect (CATE) for each patient, with larger CATEs indicating that ADAPT is expected to be more advantageous. Patients were stratified by CATEs, and outcomes were compared between treatment groups. Results Among 6700 included patients, ADAPT (n=3695, 55%) was associated with a higher rate of FPE with no sICH (39.9% vs 26.9%; adjusted OR (aOR) 2.07, 95% CI 1.77 to 2.41, P<0.001). The causal forest identified significant treatment effect heterogeneity (interaction P<0.001), where ADAPT was more advantageous in more recent years and among patients with M1 occlusions presenting in earlier time windows. Low-CATE patients showed no statistically significant difference between techniques (aOR 0.91, 95% CI 0.57 to 1.45, P=0.70), while medium- and high-CATE patients demonstrated progressively larger ADAPT advantages (aOR 2.06, 95% CI 1.67 to 2.55, and aOR 2.99, 95% CI 2.24 to 3.98, respectively, both P<0.001). Conclusions ADAPT may be superior to SR for a majority of patients, particularly in recent years, and among patients with M1 occlusions presenting in earlier time windows.
E-034 Geographic disparities in functional recovery after successful thrombectomy in the United States
Hijazi, D, Chacon, A, Chalhoub, R, Tfaily, A, Spiotta, A, Rai, A, Wolfe, S, Jabbour, P, Ogilvy, C, Ezzeldin, M, Mascitelli, J, Siddiqui, F, Howard, B, Cawley, M, Altschul, D, Park, M, Levitt, M, Brinjikji, W, Moss, M, Dye, J, Limaye, K, Alaraj, A, Kan, P, Polifka, A, Grandhi, R, Mokin, M, Starke, R, Guess, S, Surbhi, S, Goyal, N, Grossberg, J, Alawieh, A, Chalhoub, Reda, Spiotta, A, Rai, A , Jabbour, Pascal , Ogilvy, C, Ezzeldin, Mohamad , Mascitelli, J, Siddiqui, Fazeel , Howard, Brian M., Moss, M, Dye, Justin , Limaye, K, Alaraj, Ali , Polifka, A, Grandhi, R, Starke, R, Surbhi, Satya , Grossberg, J

Mayo Clinic

SNIS 23rd Annual Meeting Electronic Poster Abstracts | July 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: A109.2-A110

10.1136/jnis-2026-snis.138 Get It

Spatial Configuration of Pancreatic Cancer Is Associated with Disease Recurrence after Neoadjuvant Therapy and Curative-Intent Resection
Cisneros, Luis , Toruner, Merih Deniz , Siddiqui, Zafar , Maraone, Andrea V. , Lin, Miranda , Xiao, Alexander , Thiels, Cornelius A. , Truty, Mark J. , George, Ben , Jazieh, Khalid , Scheel, Robert , Hartley, Christopher , Elhalaby, Rofyda , Dizona, Paul , Fernández-Zapico, Martín E. , Carr, Ryan M. , Cisneros, Luis H , Toruner, Merih D , Xiao, Alexander H , Thiels, Cornelius A , Scheel, Robb , McWilliams, Robert R , Maley, Carlo C. , Hartley, Christopher P , Elhalaby, Rofyda Essam , Dizona, Paul , Shi, Qian , Fernandez-Zapico, Martin E , Carr, Ryan M , Truty, Mark J , Garzaro, Andrea V. Maraone , Lin, Miranda , George, Ben , McWilliams, Robert R. , Shi, Qian

Mayo Clinic

Clinical Cancer Research | July 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: OF1-OF16

10.1158/1078-0432.ccr-25-4968 | PMID 42456051 Get It

Abstract Purpose: Pancreatic ductal adenocarcinoma (PDAC) frequently recurs after neoadjuvant therapy (NT) and curative-intent resection. Although major pathologic response predicts favorable outcomes, most patients achieve only minor response with a heterogeneous recurrence risk. We asked whether the spatial organization of residual PDAC encodes clinically relevant biology beyond residual tumor burden. Experimental Design: In a retrospective cohort of 203 patients with resected PDAC treated with NT and restricted to minor pathologic response, routine hematoxylin and eosin (H&E) whole-slide images were segmented into cancer and stroma using an artificial intelligence–enabled pipeline. Spatial composition (patch density, edge density) and configuration (compactness/complexity, intermixing) were quantified and tested for associations with disease-free survival (DFS) using multivariable models adjusted for standard clinicopathologic factors. Results: Shorter DFS was associated with a fragmented, interface-rich tumor–stroma ecology featuring higher edge density and diversity and reduced homotypic aggregation, independent of clinicopathologic variables. Two spatial risk models were independently prognostic: (i) cancer mean shape index plus stromal shape index variability [adjusted hazard ratio (HR), 1.71; P = 0.003] and (ii) mean stromal patch area plus edge density (adjusted HR, 2.19; P = 0.002). Both models stratified outcomes in which pathologic response grading and residual cancer area did not. High-risk configurations were further associated with reduced intratumoral tumor-infiltrating lymphocyte (TIL) density and infiltration ratio, with relative TIL accumulation at the cancer periphery and within the stroma, consistent with an immune-excluded phenotype. Conclusions: Residual cancer–stroma topology quantified from standard H&E slides yields independent prognostic signals after NT in PDAC, provides a cellular immune correlate for spatial risk, and motivates prospective validation and spatially informed adjuvant strategies.
Minor stroke, major stakes: impact of procedure duration on thrombectomy outcomes in minor stroke
Kasem, Rahim Abo, Baba, Bachar El, Ma, Tianwen, Zelmanovich, Rebecca, Pabaney, Aqueel, Khelo, Roy Raheb, Giraudo, Francesca, Chandler, Katherine, Elawady, Sameh Samir, Chalhoub, Reda, Levitt, Michael R., Mascitelli, Justin, Cawley, Charles Michael, Akbik, Feras, Chisango, Zvipo, Wolfe, Stacey Quintero, Kim, Joon-Tae, Jabbour, Pascal, Yoshimura, Shinichi, Maier, Ilko, Ogilvy, Christopher S., Ezzeldin, Mohamad, Psychogios, Marios-Nikos, Siddiqui, Fazeel, Navia, Pedro, Goyal, Nitin, Arthur, Adam S., Romano, Daniele G., Fragata, Isabel, Daglioglu, Ergun, Altschul, David, Park, Min S., Crosa, Roberto, Brinjikji, Waleed, Moss, Mark, Dye, Justin, Alaraj, Ali, Kan, Peter, Limaye, Kaustubh, Mokin, Maxim, Starke, Robert M., Spiotta, Alejandro M., Grossberg, Jonathan A , Alawieh, Ali M., Kasem, Rahim Abo , Baba, Bachar El , Ma, Tianwen , Zelmanovich, Rebecca , Pabaney, Aqueel, Khelo, Roy Raheb , Giraudo, Francesca, Chacón-Aponte, Ariana Alejandra , Chandler, Katherine , Elawady, Sameh Samir , Howard, Brian M , Levitt, Michael R. , Grandhi, Ramesh , Mascitelli, Justin R , Cawley, Charles Michael, Akbik, Feras , Chisango, Zvipo Mutsa , Wolfe, Stacey Q , Kim, Joon‐Tae , Jabbour, Pascal , Maier, Ilko , Ogilvy, Christopher S. , Ezzeldin, Mohamad , Psychogios, Marios‐Nikos , Navía, Pedro , Goyal, Nitin , Arthur, Adam S., Romano, Daniele Giuseppe , Fragata, Isabel , Dağlıoğlu, Ergün , Altschul, David , Crosa, Roberto , Brinjikji, Waleed , Moss, Mark, Dye, Justin , Alaraj, Ali , Limaye, Kaustubh , Mokin, Maxim , Starke, Robert M. , Spiotta, Alejandro M , Alawieh, Ali

Mayo Clinic

Journal of Neurosurgery | July 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-12

10.3171/2026.2.jns252558 | PMID 42468039 Get It

OBJECTIVE Endovascular thrombectomy (EVT) for acute large-vessel occlusion stroke is well established, yet its role in patients presenting with minor stroke symptoms (National Institutes of Health Stroke Scale [NIHSS] score < 6) remains unclear. Prior studies have not accounted for intraprocedural factors that may influence outcomes in this subgroup. METHODS The authors analyzed 5693 patients from the STAR (Stroke and Thrombectomy and Aneurysm Registry), including 398 with low NIHSS scores, to evaluate the association between procedure time (PT) and outcomes. Among patients with low NIHSS scores, propensity score matching was used to compare outcomes between those with PT ≤ 35 versus > 35 minutes, a cutoff defined using receiver operating characteristic curve analysis. The authors performed a meta-analysis of studies reporting best medical management (BMM) outcomes in patients with low NIHSS scores. To compare these with EVT-treated patients, a matched BMM comparator cohort using stratification on pooled baseline characteristics was constructed. Outcomes included 90-day functional independence (modified Rankin Scale [mRS] scores 0–2), intracranial hemorrhage, and mortality. RESULTS PT had a stronger negative effect on outcomes in patients with low NIHSS scores compared with those with high scores, with a steeper decline in functional independence per minute of PT (slope: –0.45% vs –0.21%; p = 0.03 for interaction). Among patients with low scores, PT ≤ 35 minutes was associated with higher 90-day functional independence compared with the propensity score–matching cohort with PT > 35 minutes (82.6% vs 59.0%, p < 0.001). When benchmarked against BMM (75.2% mRS scores 0–2), patients undergoing EVT within 35 minutes had superior outcomes (85.1%, p = 0.047). In contrast, EVT with PT > 35 minutes resulted in worse outcomes than BMM (mRS scores 0–2: 59.8%, p = 0.008). The number needed to treat for PT ≤ 35 minutes was 10, whereas PT > 35 minutes yielded a number needed to harm of 6. CONCLUSIONS PT critically modulates the benefit of EVT in minor stroke. While efficient EVT yields better outcomes than BMM, prolonged procedures are associated with harm. These findings may explain prior inconsistent evidence on EVT in patients with low NIHSS scores and underscore the need to individualize procedural thresholds in this population.
Active Cerebrospinal Fluid Exchange Versus External Ventricular Drainage in IVH and SAH: A Meta-Analysis
Röblom, Albin, Niemelä, Mika, Salman, Saif , Tawk, Rabih G. , Jahromi, Babak S. , Freeman, William D. , Kashefiolasl, Sepide , Dashti, Reza , Jahromi, Behnam Rezai , Röblom, Albin , Salman, Saif D, Siddiqui, Adnan H , Tawk, Rabih G , Jahromi, Babak S , Freeman, William D , Kashefiolasl, Sepide , Dashti, Reza , Rezai Jahromi, Behnam , Bahadori, Amir Reza , Niemela, Mika R. , Siddiqui, Adnan H.

Mayo Clinic

Stroke: Vascular and Interventional Neurology | July 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/svin.125.002212 | PMID 42707794 Get It

BACKGROUND: Intraventricular hemorrhage and subarachnoid hemorrhage are associated with neuroinflammation and increased morbidity and mortality. Rapid clearance of blood from the cerebrospinal fluid space may mitigate neuroinflammatory cascades and improve clinical outcomes. This systematic review and meta-analysis aimed to compare the clinical effectiveness of active cerebrospinal fluid exchange, including neuroendoscopic lavage and IRRAflow systems, versus external ventricular drainage in patients with intraventricular hemorrhage or subarachnoid hemorrhage. METHODS: The study followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and thoroughly assessed databases, including PubMed, Embase, Scopus, Cochrane, and Web of Science, up to September 18, 2025. Statistical analysis, both fixed-effect and random-effect model analyses, was performed by the Comprehensive Meta-Analysis software. In addition, the Cochran Q test was conducted to determine the statistical heterogeneity. In terms of low heterogeneity, the fixed-effect model is reported. RESULTS: This review included 7 studies with a total sample size of 834. Our analysis showed that active cerebrospinal fluid exchange was associated with significantly higher hematoma clearance (odds ratio, 2.72 [95% CI, 1.22–6.08]; P =0.015), better functional outcomes (odds ratio, 1.66 [95% CI, 1.12–2.48]; P =0.012), lower shunt dependency (odds ratio, 0.22 [95% CI, 0.10–0.50]; P <0.001), and reduced infection rates (odds ratio, 0.22 [95% CI, 0.12–0.42]; P <0.001). Subgroup analysis showed that neuroendoscopic lavage was most effective for hematoma clearance, while IRRAflow reduced infection rates. Also, younger patients had better neurological recovery. CONCLUSIONS: Active cerebrospinal fluid exchange techniques demonstrated superior outcomes over external ventricular drainage in managing intraventricular hemorrhage and subarachnoid hemorrhage, particularly in clot resolution and neurological recovery. Large-scale trials are warranted.
Quantifying performance of high-density mapping catheters in in-vivo and benchtop models
Kapa, S, Siddiqui, U, Maddox, W, Friedman, D, Wenzel, G, Mekala, P, Mitkar, A, Deno, D C, Rippke, J, Barbhaiya, C, Siddiqui, Usman, Maddox, William R. , Wenzel, G, Deno, Don Curtis, Barbhaiya, Chirag R.

Mayo Clinic

Europace | June 25, 2026 | Volume: 28 | Issue: Supplement_1 | Pages: No page available

10.1093/europace/euag105.009 Get It

Abstract Background/Introduction High-density mapping catheters enhance the speed and accuracy of 3-dimensional data collection. However, differences in data acquisition, efficiency, and system processing are not well quantified, even for catheters with similar form factors. Purpose Compare in-vivo and bench performance of the HD Grid X (EnSite X v 5.0.1) and Optrell (Carto v 8.1.1) catheters. Criteria include mapping and modeling efficiency, electrogram (EGM) amplitude dependence on orientation, and resolution of low voltage boundaries. Methods In-vivo: In 6 swine, 5 physicians used each catheter in a randomized order to create models of equivalent detail of the left atrium (LA) and ventricle (LV) during atrial pacing. Comparable mapping parameters were selected between the respective mapping systems. Each mapping catheter was then placed in a stable location at 3 different anatomical sites in the LA and rotated while collecting manual map points. In the right atrium (RA), an independent operator placed groups of 5-6 radiofrequency (RF) lesions with a focal ablation catheter. Each physician, being blinded to the ablated areas, remapped the RA and identified the area(s) they assessed as being ablated. The indicated regions were measured on the mapping system and compared to the actual ablated area(s) observed during necropsy. Bench: Using a wavefront emulator platform, 2 propagation patterns were created—case 1: a single uniform wavefront propagating across the platform, and case 2: two uniform wavefronts colliding in the center of the platform creating a low-voltage region. For both cases, during map collection, the catheter was oriented at 3 different angles (0, 45, and 90 deg.) relative to the propagation direction. For case 1, the EGM amplitudes were compared. For case 2, the spatial resolution of the low-voltage region was defined by the full-width at half max (FWHM), i.e., the measured width of the area containing less than half the max amplitude. Results In-Vivo: Median rate of mapping point acquisition for Grid X was higher than Optrell by 167% (p=0.02; 48,18 points/s) in the LA and 39% (p=0.03; 18,13 points/s) in the LV. Median time for model completion for Grid X was shorter than Optrell by 39% (p=0.047; 318s, 525s) in the LA and 45% (p=0.02; 342s, 620s) in the LV. Grid X measured higher amplitude EGMs in all 3 LA locations (Fig 1). The mean error in the lesion areas identified by Grid X was 25% lower than Optrell (p=0.04; 154, 204 mm²). Bench: In case 1, Grid X recorded a median normalized amplitude which was 58% larger than Optrell (Fig 1). In case 2, Grid X recorded a median voltage resolution which was 34% finer than Optrell (Fig 2). Conclusion Design considerations beyond catheter shape may impact mapping quality and speed. Grid X collects mapping and geometry data faster, is less reliant on catheter orientation to collect high voltage EGMs, and more accurately defines low voltage boundaries compared to Optrell.Figure 1:EGM Amplitude DataFigure 2:Voltage Resolution
Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement
Xiao, Alexander , Zanwar, Saurabh , Lin, Yi, Kapoor, Prashant , Abdallah, Nadine , Baudi, Francis, Dingli, David, Gertz, Morie A. , Gonsalves, Wilson I, Hayman, Suzanne R. , Kourelis, Taxiarchis , Tan, Melinda SY, Warsame, Rahma , Rajkumar, S Vincent, Kumar, Shaji , Dingli, David , Buadi, Francis K. , Lin, Yi , Lin, Yi , Buadi, Francis K , Binder, Moritz , Dispenzieri, Angela , Dingli, David , Gertz, Morie A , Gonsalves, Wilson , Kourelis, Taxiarchis , Leung, Nelson , Muchtar, E , Siddiqui, Mustaqeem A , Tan, Melinda , Warsame, Rahma , Rajkumar, S Vincent , Kumar, Shaji K , Xiao, Alexander H , Binder, Moritz , Dispenzieri, Angela , Gonsalves, Wilson I. , Leung, Nelson , Muchtar, Eli , Siddiqui, Mustaqeem , Rajkumar, S. Vincent

Mayo Clinic

Blood Advances | June 25, 2026 | Volume: 10 | Issue: 17 | Pages: 5828-5833

10.1182/bloodadvances.2026020668 | PMID 42348786 Get It

Abstract Extramedullary disease (EMD) is increasingly recognized in relapsed/refractory multiple myeloma (MM), with central nervous system involvement (CNS-MM) representing a rare but highly aggressive manifestation associated with dismal outcomes. Data on its incidence and optimal management, particularly in the era of cellular and bispecific therapies, remain limited. We conducted a retrospective analysis of patients with MM with pathology-confirmed EMD treated at our institution between January 2000 and December 2023. CNS-MM was defined by parenchymal or leptomeningeal involvement. Clinical features, cytogenetics, treatments, and outcomes were analyzed, with predictors of CNS involvement evaluated among patients with EMD. Among 304 patients with EMD, 20 (6.5%) had CNS-MM. CNS involvement occurred a median of 19.2 months after MM diagnosis, though 15% presented at diagnosis. CNS-MM was strongly associated with high-risk cytogenetics (odds ratio [OR], 3.7) and additional visceral EMD (OR, 4.6). Median overall survival (OS) from CNS-MM diagnosis was 4.2 months. Outcomes were significantly improved in patients receiving chimeric antigen receptor T-cell therapy or bispecific antibodies, with a median OS of 19.2 months vs 1.2 months in those who did not receive immune effector therapies. Intrathecal (IT) chemotherapy demonstrated limited and transient benefit. In conclusion, CNS-MM is an aggressive complication enriched in high-risk, multifocal EMD with extremely poor prognosis. Cellular and bispecific therapies show promising activity and may meaningfully improve survival, whereas IT therapy appears to have limited efficacy. Prospective studies are needed to define optimal treatment strategies for CNS-MM.
Stool Microbiota, Metabolites, and Fecal Incontinence in Women
Arya, Lily A. , Kashyap, Purna , Carnes, Megan U., Mathur, Ravi, Richter, Holly E., Andy, U., Jelovsek, J. Eric, Siddiqui, Nazema Y., Morrow, Casey D. , Lefkowitz, Elliot J. , Pol, William J. Van Der, Broeckling, Corey, Carper, Benjamin, Jeney, Sarah E.S., Zyczynski, Halina M. , Dyer, Keisha Y., Carberry, Cassandra, Mazloomdoost, D., Network, for the NICHD Pelvic Floor Disorders, Arya, Lily A. , Carnes, Megan Ulmer , Mathur, Ravi , Richter, Holly E , Andy, Uduak Umoh , Pol, William J. Van Der, Broeckling, Corey D. , Carper, Benjamin , Jeney, Sarah E.S. , Carberry, Cassandra, Mazloomdoost, Donna , Gantz, Marie G.

Mayo Clinic

Urogynecology | June 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/spv.0000000000001885 | PMID 42240124 Get It

Importance Stool metabolites influencing gut motility and sensation may contribute to fecal incontinence (FI). Objective The objective of this study was to test whether FI is associated with higher levels of butyrate and Clostridiales taxa in stool. Study Design Stool metabolites and microbiota were compared between 96 women with FI and 42 controls. FI frequency and subtype (urgency vs insensible) were measured using a 14-day bowel diary, St. Mark’s score, and the Accidental Bowel Leakage questionnaire. Metabolite analysis included targeted analysis (8 short-chain fatty acids including butyrate, 17 bile acids, and 8 tryptophan derivatives) and untargeted analysis. Stool microbiota were characterized using 16S rRNA gene sequencing. Multivariable and exploratory multiomics factor analysis were performed with statistical significance defined as false discovery rate (FDR) ≤0.10. Results The FI group had a higher proportion of Bristol stool types 2 and 6 than controls ( P = 0.005). The mean number of leaks for the FI group was 1.7 ± 1.7 per day, 38% had urgency FI, and 39% had insensible FI. There was no significant difference between groups in butyrate levels and Clostridiales taxa. Multiomics analysis identified glycerolipids (monoacylglycerols and diacylglycerols) associated with FI (FDR = 0.08). In addition, insensible FI was associated with glycerolipids, long-chain saturated and monounsaturated fatty acids, phospholipids, and dipeptides (FDR = 0.08–0.09). The top weighted microbiota associated with these metabolites were Lachnospiraceae and Ruminococcaceae; however, these taxa were not directly associated with FI. Conclusion Butyrate and Clostridiales were not associated with FI. Novel stool metabolite signatures were identified, suggesting new biological pathways and potential therapeutic targets for FI.